Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide

Published:2018-12-11 Issue:7 Volume:144 Page:1735-1745
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Johannessen Tor‐Christian¹²,Hasan‐Olive Md Mahdi¹,Zhu Huaiyang¹³,Denisova Oxana⁴,Grudic Amra¹,Latif Md Abdul¹,Saed Halala¹,Varughese Jobin K.¹,Røsland Gro Vatne⁵,Yang Ning¹⁶⁷,Sundstrøm Terje¹⁸,Nordal Anne⁹,Tronstad Karl Johan⁵,Wang Jian¹⁶⁷,Lund‐Johansen Morten⁸¹⁰,Simonsen Anne¹¹,Janji Bassam¹²,Westermarck Jukka⁴,Bjerkvig Rolf¹¹³,Prestegarden Lars¹⁹¹⁰^ORCID

Affiliation:

1. Kristian Gerhard Jebsen Brain Tumor Research Centre, Department of BiomedicineUniversity of Bergen Bergen Norway

2. Department of OncologyHaukeland University Hospital Bergen Norway

3. Department of OncologyShandong Chest Hospital Jinan China

4. Turku Centre for BiotechnologyUniversity of Turku and Åbo Akademi University Turku Finland

5. Department of BiomedicineUniversity of Bergen Bergen Norway

6. Department of NeurosurgeryQilu Hospital of Shandong University Jinan China

7. Brain Science Research InstituteShandong University Jinan China

8. Department of NeurosurgeryHaukeland University Hospital Bergen Norway

9. Department of DermatologyHaukeland University Hospital Bergen Norway

10. Department of Clinical MedicineUniversity of Bergen Bergen Norway

11. Department of Molecular MedicineInstitute of Basic Medical Sciences University of Oslo, Oslo Norway

12. Laboratory of Experimental Hemato‐Oncology, Department of OncologyLuxembourg Institute of Health (LIH) Luxembourg City Luxembourg

13. NorLux Neuro‐Oncology Laboratory, Department of OncologyLuxembourg Institute of Health Luxembourg

Funder

Helse Vest

Jane ja Aatos Erkon Säätiö

Kreftforeningen

Norges Forskningsråd

Qilu Hospital of Shandong University

Stiftelsen Kristian Gerhard Jebsen

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31912

Reference33 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

3. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

4. ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents

5. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11

2. Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and In Vitro Effect on Glioblastoma;ACS Omega;2024-04-05

4. Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy;Biochemical Pharmacology;2024-04

5. Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates;FEBS Open Bio;2024-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3